查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1518283

2024 年连续性肾臟替代疗法全球市场报告

Continuous Renal Replacement Therapy Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

持续性肾臟替代治疗市场规模预计在未来几年将快速成长。 2028年，将以11.1%的复合年增长率成长至23.8亿美元。预计的增长因素包括慢性肾臟病的增加、导致肾臟併发症的糖尿病盛行率的增加、需要肾臟支持的加护病房（ICU）入院人数的增加以及支持肾臟护理服务的医疗支持，其中包括增加投资。预测期内的主要趋势包括 CRRT 技术的快速进步、新 CRRT 技术的推出、该领域的持续技术进步、持续的产品创新以及满足不同患者需求的技术进步，其中包括采用先进的 CRRT 产品。

慢性肾臟病的增加有望推动未来几年持续肾臟替代治疗市场的成长。慢性肾臟病（CKD）是一种持续性疾病，其特征是肾功能逐渐衰退以及血液中废物的清除受损。导致慢性肾臟病盛行率增加的因素包括生活方式的改变、人口老化以及糖尿病和高血压盛行率的增加。连续肾臟替代疗法用于治疗慢性肾臟病的急性恶化和併发症，调节体液平衡并持续清除代谢废物。例如，根据美国疾病管制与预防中心 2022 年 7 月报告，肾臟疾病影响约 15% 的美国美国，即 3,700 万人。此外，澳洲健康与福利研究所指出，2019 年至 2020 年间，肾臟替代疗法的普及率将从每 10 万人 94 人增加到 95.4 人。这一趋势支持了对持续肾臟替代疗法不断增长的需求。

连续性肾臟替代治疗市场的领导者正专注于开发先进产品，例如连续性肾臟替代疗法 (CRRT) 平台，以为客户提供增强功能。 CRRT 平台包含用于提供 CRRT 的系统和技术，CRRT 是一种主要针对无法接受定期血液透析机的重症患者的透析方法。例如，Baxter International Inc.于2021年5月推出了Prismax 2平台，旨在简化连续肾臟替代疗法和其他器官支持疗法的管理。该平台由百特 TrueVue 数位健康产品组合的 Prismalung+ 血气交换器提供支持，为医院提供应对 ICU 挑战所需的灵活性，为急性呼吸功能障碍管理 (ECCO2R) 治疗提供体外二氧化碳移除。

目录

第一章执行概述

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球连续性肾臟替代治疗市场：驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 全球连续肾臟替代治疗市场表现：规模与成长，2018-2023
  • 全球连续肾臟替代疗法市场预测：规模与成长，2023-2028 年、2033 年

第六章 市场细分

  • 全球连续肾臟替代治疗市场：依产品、表现及预测，2018-2023、2023-2028、2033
  • 系统
  • 消耗品
  • 全球连续性肾臟替代治疗市场：依治疗、表现及预测，2018-2023、2023-2028、2033
  • 肾
  • 非肾
  • 全球连续肾臟替代治疗市场：按方式、表现和预测，2018-2023、2023-2028、2033
  • 慢速连续超过滤(SCUF)
  • 连续性静脉血液滤过（CVVH）
  • 连续性静脉血液血液透析机（CVVHD）
  • 连续性静脉血液透析滤过（CVVHDF）
  • 全球连续肾臟替代治疗市场：依年龄层、表现及预测，2018-2023、2023-2028、2033
  • 成人
  • 儿科或新生儿
  • 全球连续肾臟替代治疗市场：按最终用户、绩效和预测，2018-2023、2023-2028、2033
  • 医院
  • 门诊治疗
  • 居家医疗

第 7 章 区域/国家分析

  • 全球连续肾臟替代治疗市场：按地区、绩效及预测，2018-2023、2023-2028、2033
  • 全球连续肾臟替代治疗市场：依国家、绩效及预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争格局及公司概况

  • 连续性肾臟替代疗法市场：竞争格局
  • 连续性肾臟替代治疗市场：公司简介
    • Medtronic Plc
    • Fresenius Medical Care AG & Co. KGaA
    • Asahi Kasei Corporation
    • Toray Industries Inc.
    • Baxter International Inc.

第31章 其他大型创新企业

  • B. Braun Melsungen AG
  • Terumo Corporation
  • Nipro Corporation
  • NxStage Medical Inc.
  • Hillrom Holdings Inc.
  • Gambro AB
  • JMS Co. Ltd.
  • Quanta Dialysis Technologies Ltd.
  • Bellco Srl
  • Ningbo Tianyi Medical Devices Co. Ltd.
  • Cytosorbents Corporation
  • Kawasumi Laboratories Inc.
  • Medica SpA
  • Informed SA
  • Medites Pharma Spol. SRO

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来展望与潜力分析

第36章附录

简介目录
Product Code: r18328

Continuous renal replacement therapy (CRRT) is a form of dialysis that provides gradual, ongoing blood filtration to help regulate levels of fluids, electrolytes, and waste products in critically ill patients with acute kidney injury (AKI) who are hemodynamically unstable. It plays a crucial role in managing fluid overload in critically ill patients, particularly those who cannot tolerate rapid fluid removal through intermittent hemodialysis due to cardiovascular instability.

The primary products in the continuous renal replacement therapy market are systems and consumables. A continuous renal replacement therapy (CRRT) system is a specialized medical device utilized in treating critically ill patients with AKI or other renal conditions. It offers various renal and non-renal therapies using different modalities such as slow continuous ultrafiltration (SCUF), continuous venovenous hemofiltration (CVVH), continuous venovenous hemodialysis (CVVHD), and continuous venovenous hemodiafiltration (CVVHDF). These therapies are administered to adults, pediatrics, and neonates in various settings including hospitals, ambulatory care centers, and homecare setups.

The continuous renal replacement therapy market research report is one of a series of new reports from The Business Research Company that provides continuous renal replacement therapy market statistics, including continuous renal replacement therapy industry global market size, regional shares, competitors with a continuous renal replacement therapy market share, detailed continuous renal replacement therapy market segments, market trends and opportunities, and any further data you may need to thrive in the continuous renal replacement therapy industry. This continuous renal replacement therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The continuous renal replacement therapy market size has grown rapidly in recent years. It will grow from $1.41 billion in 2023 to $1.57 billion in 2024 at a compound annual growth rate (CAGR) of 10.9%. The growth observed in the historic period can be attributed to several factors, including an increased demand for advanced continuous renal replacement therapy (CRRT) devices, a rise in the prevalence and incidence of acute kidney injury (AKI), an increase in the number of medical applications for CRRT, a high prevalence of co-morbidities among patients requiring CRRT, and ongoing research and development efforts in the field.

The continuous renal replacement therapy market size is expected to see rapid growth in the next few years. It will grow to $2.38 billion in 2028 at a compound annual growth rate (CAGR) of 11.1%. The forecasted growth can be attributed to several factors, including increasing incidences of chronic kidney diseases, a rising prevalence of diabetes leading to kidney complications, a growing number of intensive care unit (ICU) admissions necessitating renal support, rising investments in healthcare infrastructure to support renal care services, and expanding applications of continuous renal replacement therapy (CRRT) in pediatric care. Major trends expected in the forecast period encompass rapid advancements in CRRT technology, launches of new CRRT technologies, ongoing technological advancements in the field, continuous product innovation, and the introduction of technologically advanced CRRT products catering to diverse patient needs.

The rise in chronic kidney diseases is poised to fuel the growth of the continuous renal replacement therapy market in the coming years. Chronic kidney disease (CKD) is a persistent condition characterized by a gradual decline in kidney function, resulting in the impaired removal of waste products from the bloodstream. Factors contributing to the increasing incidence of chronic kidney diseases include lifestyle shifts, aging demographics, and rising rates of diabetes and hypertension. Continuous renal replacement therapy is employed in managing acute exacerbations or complications of chronic kidney disease to regulate fluid balance and continually eliminate metabolic waste products. For example, as reported by the Centers for Disease Control and Prevention in July 2022, kidney disease affected approximately 15% of the US population, amounting to 37 million individuals. Additionally, the Australian Institute of Health and Welfare noted an increase in the prevalence of kidney replacement therapy from 94 to 95.4 per 100,000 population between 2019 and 2020. This trend underscores the growing demand for continuous renal replacement therapy.

Leading companies in the continuous renal replacement therapy market are focusing on developing advanced products such as continuous renal replacement therapy (CRRT) platforms to cater to customers with enhanced features. CRRT platforms encompass systems and technologies utilized in delivering CRRT, a dialysis method primarily prescribed for critically ill patients unable to undergo regular hemodialysis. For instance, Baxter International Inc. introduced the Prismax 2 platform in May 2021, designed to streamline the administration of continuous renal replacement therapy and other organ support therapies. This platform, featuring the Prismalung+ blood-gas exchanger from Baxter's TrueVue digital health portfolio, offers hospitals the flexibility needed to address ICU challenges and includes extracorporeal carbon dioxide removal (ECCO2R) therapy for acute respiratory dysfunction management.

In December 2021, Baxter International Inc. completed the acquisition of Hillrom for $12.5 billion, strategically expanding its product range and expertise in hospital equipment and digital health. This acquisition strengthens Baxter's position as a global leader in medical technology, aligning with its mission to revolutionize healthcare and improve patient care worldwide. Hillrom, a US-based provider of continuous renal replacement therapy, joins forces with Baxter to advance medical technology innovation and enhance patient outcomes.

Major companies operating in the continuous renal replacement therapy market are Medtronic Plc, Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Corporation, Toray Industries Inc., Baxter International Inc., B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, NxStage Medical Inc., Hillrom Holdings Inc., Gambro AB, JMS Co. Ltd., Quanta Dialysis Technologies Ltd., Bellco S.r.l., Ningbo Tianyi Medical Devices Co. Ltd., Cytosorbents Corporation, Kawasumi Laboratories Inc., Medica S.p.A., Infomed SA , Medites Pharma Spol. S.R.O, Nikkiso Co. Ltd., Anjue Medical Equipment Co. Ltd., Medcomp Systems Ltd.

North America was the largest region in the continuous renal replacement therapy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the continuous renal replacement therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the continuous renal replacement therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The continuous renal replacement therapy (CRRT) market consists of revenues earned by entities by providing services such as acute hemodialysis, aquapheresis, and fluid management. The market value includes the value of related goods sold by the service provider or included within the service offering. The continuous renal replacement therapy market also includes sales of dialysis catheters, dialysates, hemostatic agents, and airway clearance systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Continuous Renal Replacement Therapy Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on continuous renal replacement therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for continuous renal replacement therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The continuous renal replacement therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: System; Consumables
  • 2) By Therapy: Renal; Non-Renal
  • 3) By Modality: Slow Continuous Ultra-Filtration (SCUF); Continuous Venovenous Hemofiltration (CVVH); Continuous Venovenous Hemodialysis (CVVHD); Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 4) By Age Group: Adults; Pediatrics Or Neonates
  • 5) By End-Users: Hospitals; Ambulatory Care; Homecare
  • Companies Mentioned: Medtronic Plc; Fresenius Medical Care AG & Co. KGaA; Asahi Kasei Corporation; Toray Industries Inc.; Baxter International Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Continuous Renal Replacement Therapy Market Characteristics

3. Continuous Renal Replacement Therapy Market Trends And Strategies

4. Continuous Renal Replacement Therapy Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Continuous Renal Replacement Therapy Market Size and Growth

  • 5.1. Global Continuous Renal Replacement Therapy Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Continuous Renal Replacement Therapy Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Continuous Renal Replacement Therapy Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Continuous Renal Replacement Therapy Market Segmentation

  • 6.1. Global Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • System
  • Consumables
  • 6.2. Global Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Renal
  • Non-Renal
  • 6.3. Global Continuous Renal Replacement Therapy Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Slow Continuous Ultra-Filtration (SCUF)
  • Continuous Venovenous Hemofiltration (CVVH)
  • Continuous Venovenous Hemodialysis (CVVHD)
  • Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 6.4. Global Continuous Renal Replacement Therapy Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Adults
  • Pediatrics Or Neonates
  • 6.5. Global Continuous Renal Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Ambulatory Care
  • Homecare

7. Continuous Renal Replacement Therapy Market Regional And Country Analysis

  • 7.1. Global Continuous Renal Replacement Therapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Continuous Renal Replacement Therapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Continuous Renal Replacement Therapy Market

  • 8.1. Asia-Pacific Continuous Renal Replacement Therapy Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Continuous Renal Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Continuous Renal Replacement Therapy Market

  • 9.1. China Continuous Renal Replacement Therapy Market Overview
  • 9.2. China Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Continuous Renal Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Continuous Renal Replacement Therapy Market

  • 10.1. India Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Continuous Renal Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Continuous Renal Replacement Therapy Market

  • 11.1. Japan Continuous Renal Replacement Therapy Market Overview
  • 11.2. Japan Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Continuous Renal Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Continuous Renal Replacement Therapy Market

  • 12.1. Australia Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Continuous Renal Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Continuous Renal Replacement Therapy Market

  • 13.1. Indonesia Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Continuous Renal Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Continuous Renal Replacement Therapy Market

  • 14.1. South Korea Continuous Renal Replacement Therapy Market Overview
  • 14.2. South Korea Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Continuous Renal Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Continuous Renal Replacement Therapy Market

  • 15.1. Western Europe Continuous Renal Replacement Therapy Market Overview
  • 15.2. Western Europe Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Continuous Renal Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Continuous Renal Replacement Therapy Market

  • 16.1. UK Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Continuous Renal Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Continuous Renal Replacement Therapy Market

  • 17.1. Germany Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Continuous Renal Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Continuous Renal Replacement Therapy Market

  • 18.1. France Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Continuous Renal Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Continuous Renal Replacement Therapy Market

  • 19.1. Italy Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Continuous Renal Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Continuous Renal Replacement Therapy Market

  • 20.1. Spain Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Continuous Renal Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Continuous Renal Replacement Therapy Market

  • 21.1. Eastern Europe Continuous Renal Replacement Therapy Market Overview
  • 21.2. Eastern Europe Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Continuous Renal Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Continuous Renal Replacement Therapy Market

  • 22.1. Russia Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Continuous Renal Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Continuous Renal Replacement Therapy Market

  • 23.1. North America Continuous Renal Replacement Therapy Market Overview
  • 23.2. North America Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Continuous Renal Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Continuous Renal Replacement Therapy Market

  • 24.1. USA Continuous Renal Replacement Therapy Market Overview
  • 24.2. USA Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Continuous Renal Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Continuous Renal Replacement Therapy Market

  • 25.1. Canada Continuous Renal Replacement Therapy Market Overview
  • 25.2. Canada Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Continuous Renal Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Continuous Renal Replacement Therapy Market

  • 26.1. South America Continuous Renal Replacement Therapy Market Overview
  • 26.2. South America Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Continuous Renal Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Continuous Renal Replacement Therapy Market

  • 27.1. Brazil Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Continuous Renal Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Continuous Renal Replacement Therapy Market

  • 28.1. Middle East Continuous Renal Replacement Therapy Market Overview
  • 28.2. Middle East Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Continuous Renal Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Continuous Renal Replacement Therapy Market

  • 29.1. Africa Continuous Renal Replacement Therapy Market Overview
  • 29.2. Africa Continuous Renal Replacement Therapy Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Continuous Renal Replacement Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Continuous Renal Replacement Therapy Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Continuous Renal Replacement Therapy Market Competitive Landscape And Company Profiles

  • 30.1. Continuous Renal Replacement Therapy Market Competitive Landscape
  • 30.2. Continuous Renal Replacement Therapy Market Company Profiles
    • 30.2.1. Medtronic Plc
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Fresenius Medical Care AG & Co. KGaA
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Asahi Kasei Corporation
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Toray Industries Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Baxter International Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Continuous Renal Replacement Therapy Market Other Major And Innovative Companies

  • 31.1. B. Braun Melsungen AG
  • 31.2. Terumo Corporation
  • 31.3. Nipro Corporation
  • 31.4. NxStage Medical Inc.
  • 31.5. Hillrom Holdings Inc.
  • 31.6. Gambro AB
  • 31.7. JMS Co. Ltd.
  • 31.8. Quanta Dialysis Technologies Ltd.
  • 31.9. Bellco S.r.l.
  • 31.10. Ningbo Tianyi Medical Devices Co. Ltd.
  • 31.11. Cytosorbents Corporation
  • 31.12. Kawasumi Laboratories Inc.
  • 31.13. Medica S.p.A.
  • 31.14. Informed SA
  • 31.15. Medites Pharma Spol. S.R.O

32. Global Continuous Renal Replacement Therapy Market Competitive Benchmarking

33. Global Continuous Renal Replacement Therapy Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Continuous Renal Replacement Therapy Market

35. Continuous Renal Replacement Therapy Market Future Outlook and Potential Analysis

  • 35.1 Continuous Renal Replacement Therapy Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Continuous Renal Replacement Therapy Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Continuous Renal Replacement Therapy Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer